Assuntos
Comércio/métodos , Anticoncepção Pós-Coito/tendências , Militares/psicologia , Guerra/estatística & dados numéricos , Adulto , Comércio/estatística & dados numéricos , Estudos Transversais , Feminino , Acessibilidade aos Serviços de Saúde/normas , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Humanos , Militares/estatística & dados numéricos , Estados UnidosAssuntos
COVID-19/epidemiologia , Anticoncepção Pós-Coito/tendências , Serviços de Planejamento Familiar/tendências , Assistência Centrada no Paciente/tendências , Período Pós-Parto , Feminino , Acessibilidade aos Serviços de Saúde/tendências , Humanos , Cuidado Pós-Natal/tendências , Gravidez , Reino UnidoAssuntos
Betacoronavirus , Anticoncepção Pós-Coito/estatística & dados numéricos , Infecções por Coronavirus/psicologia , Comportamentos Relacionados com a Saúde/classificação , Pneumonia Viral/psicologia , Adolescente , Fatores Etários , COVID-19 , Anticoncepção Pós-Coito/psicologia , Anticoncepção Pós-Coito/tendências , Infecções por Coronavirus/prevenção & controle , Humanos , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , SARS-CoV-2 , Adulto JovemRESUMO
OBJECTIVES: This Kenya-based study ascertained whether pharmacies were an untapped source of 'youth-friendly' health services by determining (1) whether young people (aged 18-24) could successfully obtain condoms and emergency contraception (ECP); (2) whether contraceptives were dispensed according to national guidelines; and (3) how young people felt about obtaining ECP and condoms from pharmacy personnel. METHODS: This study used several methods to capture and cross-check purchasing experiences as reported by young people with those of dispensing pharmacy personnel. These included: focus group discussions; in-depth interviews; key informant interviews; and mystery shoppers. RESULTS: When in stock, young people were successfully able to obtain ECP and condoms from pharmacies. Counselling was sporadic: when it happened, it was not always accurate. Despite a lack of counselling, young people reported being satisfied with the quick, transactional interaction with pharmacy personnel. CONCLUSIONS: The brief, transactional interactions between pharmacy personnel and young clients appear to be 'youth-friendly enough'. While there is room to strengthen the services provided (improving both accuracy and scope), this should be done in a manner that does not fundamentally alter the current interaction.
Assuntos
Preservativos/provisão & distribuição , Comportamento do Consumidor , Anticoncepção Pós-Coito/tendências , Assistência Farmacêutica/organização & administração , Farmacêuticos , Adolescente , Anticoncepção/tendências , Feminino , Grupos Focais , Educação em Saúde/organização & administração , Humanos , Quênia , Masculino , Adulto JovemRESUMO
PURPOSE OF REVIEW: As politics continue to shape contraception and abortion care, providers have a responsibility to address the specific needs of the adolescent patient. Here we review the current literature on contraception and abortion in adolescents. RECENT FINDINGS: Shared decision-making among patients, parents, and providers is the cornerstone of successful adolescent family planning. Providers should be aware of local state regulations related to consent in minors. When provided directive and noncoercive contraception counseling at no cost, adolescents are motivated and effective decision-makers in their care. Long-acting reversible contraceptives should be offered as the first-line method of contraception in adolescents. SUMMARY: Family planning in adolescents presents unique challenges to obstetrician-gynecologists. Improved access to contraception and abortion services is significantly lowering unintended pregnancies rates in adolescents, but more data assessing the effectiveness of interventions in marginalized communities are needed.
Assuntos
Aborto Induzido/legislação & jurisprudência , Aborto Induzido/tendências , Medicina do Adolescente/tendências , Anticoncepção/tendências , Serviços de Planejamento Familiar/legislação & jurisprudência , Contracepção Reversível de Longo Prazo/tendências , Adolescente , Anticoncepção Pós-Coito/tendências , Tomada de Decisões , Feminino , Ginecologia/tendências , Humanos , Dispositivos Intrauterinos/tendências , Obstetrícia/tendências , Pais , Gravidez , Gravidez não PlanejadaRESUMO
PURPOSE OF REVIEW: Emergency contraception provides a critical and time-sensitive opportunity for women to prevent undesired pregnancy after intercourse. Both access and available options for emergency contraception have changed over the last several years. RECENT FINDINGS: Emergency contraceptive pills can be less effective in obese women. The maximum achieved serum concentration of levonorgestrel (LNG) is lower in obese women than women of normal BMI, and doubling the dose of LNG (3âmg) increases its concentration maximum, approximating the level in normal BMI women receiving one dose of LNG. Repeated use of both LNG and ulipristal acetate (UPA) is well tolerated. Hormonal contraception can be immediately started following LNG use, but should be delayed for 5 days after UPA use to avoid dampening the efficacy of UPA. The copper intrauterine device (IUD) is the only IUD approved for emergency contraception (and the most effective method of emergency contraception), but use of LNG IUD as emergency contraception is currently being investigated. Accurate knowledge about emergency contraception remains low both for patients and healthcare providers. SUMMARY: Emergency contraception is an important yet underutilized tool available to women to prevent pregnancy. Current options including copper IUD and emergency contraceptive pills are safe and well tolerated. Significant gaps in knowledge of emergency contraception on both the provider and user level exist, as do barriers to expedient access of emergency contraception.
Assuntos
Anticoncepção Pós-Coito/tendências , Anticoncepcionais Femininos/administração & dosagem , Anticoncepcionais Pós-Coito/administração & dosagem , Adulto , Anticoncepção , Feminino , Acessibilidade aos Serviços de Saúde , Humanos , Dispositivos Intrauterinos de Cobre , Levanogestrel/administração & dosagem , Norpregnadienos/administração & dosagem , Obesidade/complicações , GravidezRESUMO
Background: Emergency contraception refers to contraceptive methods that can be used after a sexual intercourse Aim: To analyze the evolution of emergency contraception (EC) consultations on the Chilean public health system, at a communal level, in relation to the legal changes that recently took place, aimed to ease the delivery of the benefit. To analyze its association with socioeconomic, demographic and municipal healthcare system characteristics. Material and Methods: We analyzed data bases of the Ministry of Health to study EC consultation rates on Chilean communes, including consultations on emergency departments and by rape, from 2008 to 2013. We evaluated the association with communal characteristics, obtained from the National Municipal Information System. Results: Both the communal consultation rates and percentage of communes with consultations increased progressively during the period, with an explosive increase between 2009 and 2010. We observed a high dispersion in EC consultations both at a communal and regional level. There was an inverse significant association of the number of consultations with the communal poverty rate. Conclusions: Our results reveal the impact of legal modifications implemented in Chile since 2009 on the communal EC consultation rates. On other hand, our results reveal that although these modifications were oriented to favor the delivery of this benefit, a high dispersion subsists, associated with populations socioeconomic factors, mainly, the communal poverty level.
Assuntos
Humanos , Feminino , Criança , Adolescente , Adulto , Adulto Jovem , Encaminhamento e Consulta/estatística & dados numéricos , Atenção à Saúde/estatística & dados numéricos , Anticoncepção Pós-Coito/estatística & dados numéricos , Pobreza/estatística & dados numéricos , Estupro/estatística & dados numéricos , Encaminhamento e Consulta/tendências , Fatores Socioeconômicos , Chile , Estudos Retrospectivos , Estudos Longitudinais , Atenção à Saúde/legislação & jurisprudência , Anticoncepção Pós-Coito/tendênciasRESUMO
OBJECTIVE: To examine the changes in the prevalence of, and the factors associated with, the use of emergency contraception (EC) in Britain between 2000 and 2010, spanning the period of deregulation and increase in pharmacy supply. DESIGN: Cross-sectional probability sample surveys. SETTING AND POPULATION: British general population. METHODS: Data were analysed from the second and third British National Surveys of Sexual Attitudes and Lifestyles (Natsal), undertaken in 1999-2001 and 2010-12. Univariate and logistic regression analyses were used to measure change in EC use amongst sexually active women aged 16-44 years not intending pregnancy. MAIN OUTCOME MEASURES: Prevalence of EC use and factors associated with use. RESULTS: Of the 5430 women surveyed in 1999-2001 and the 4825 women surveyed in 2010-12, 2.3 and 3.6%, respectively, reported using EC in the year prior to interview (P = 0.0019 for change over time). The prevalence of EC use increased amongst single women and those with higher educational attainment (adjusted odds ratio, aOR 1.51; 95% confidence interval, 95% CI 1.04-2.20; P = 0.0308). Increases in EC use were generally greater among women without behavioural risk factors, such as those with no history of abortion within 5 years (aOR 1.57; 95% CI 1.17-2.12; P = 0.0029), or those whose first heterosexual intercourse occurred after the age of 16 years (aOR 1.68; 95% CI 1.21-2.35; P = 0.0021). The increase in EC use was also more marked among women usually accessing contraception from retail sources than among those doing so from healthcare sources, which may reflect a use of condoms amongst EC users. CONCLUSION: The increase in EC use among women in Britain in the first decade of the 21st century was associated with some, but not all, risk factors for unplanned pregnancy. Advice and provision may need to be targeted at those at highest risk of unplanned pregnancy. TWEETABLE ABSTRACT: Despite pharmacy access, only a small rise in emergency contraception use has been seen in Britain over 10 years.
Assuntos
Aborto Induzido/estatística & dados numéricos , Atitude , Anticoncepção Pós-Coito/estatística & dados numéricos , Anticoncepção Pós-Coito/tendências , Estilo de Vida , Comportamento Sexual/estatística & dados numéricos , Adolescente , Adulto , Estudos Transversais , Feminino , Humanos , Gravidez , Prevalência , Fatores de Risco , Reino Unido/epidemiologiaRESUMO
BACKGROUND: Emergency contraception refers to contraceptive methods that can be used after a sexual intercourse Aim: To analyze the evolution of emergency contraception (EC) consultations on the Chilean public health system, at a communal level, in relation to the legal changes that recently took place, aimed to ease the delivery of the benefit. To analyze its association with socioeconomic, demographic and municipal healthcare system characteristics. MATERIAL AND METHODS: We analyzed data bases of the Ministry of Health to study EC consultation rates on Chilean communes, including consultations on emergency departments and by rape, from 2008 to 2013. We evaluated the association with communal characteristics, obtained from the National Municipal Information System. RESULTS: Both the communal consultation rates and percentage of communes with consultations increased progressively during the period, with an explosive increase between 2009 and 2010. We observed a high dispersion in EC consultations both at a communal and regional level. There was an inverse significant association of the number of consultations with the communal poverty rate. CONCLUSIONS: Our results reveal the impact of legal modifications implemented in Chile since 2009 on the communal EC consultation rates. On other hand, our results reveal that although these modifications were oriented to favor the delivery of this benefit, a high dispersion subsists, associated with populations socioeconomic factors, mainly, the communal poverty level.
Assuntos
Anticoncepção Pós-Coito/estatística & dados numéricos , Atenção à Saúde/estatística & dados numéricos , Encaminhamento e Consulta/estatística & dados numéricos , Adolescente , Adulto , Criança , Chile , Anticoncepção Pós-Coito/tendências , Atenção à Saúde/legislação & jurisprudência , Feminino , Humanos , Estudos Longitudinais , Pobreza/estatística & dados numéricos , Estupro/estatística & dados numéricos , Encaminhamento e Consulta/tendências , Estudos Retrospectivos , Fatores Socioeconômicos , Adulto JovemRESUMO
BACKGROUND: The growing popularity of emergency contraceptives (ECs) among urban youth in Sub-Saharan Africa is accompanied by debates on morality and health. This study was situated in Addis Ababa, Ethiopia and aimed to explore how these debates affect the way in which the product is promoted at a national level, how it is dispensed by service providers, and how young people access, purchase, and get informed about ECs. METHODS: Data were collected using qualitative methods: observations in pharmacies, administering semi-structured questionnaires to young people in pharmacies (N = 36), informal interviews with young people (N = 65), and in-depth interviews with service providers (N = 8) and key stakeholders (N = 3). RESULTS: Key stakeholders, uncomfortable with high sales of ECs, and service providers, worried about women's health, promiscuity and the neglect of condoms, stay silent about ECs. Most young people had used ECs more than once. In a context where premarital sex is morally sanctioned ECs provide young people with a way of keeping their sexual lives secret and they fit well with their sex lives that often entail infrequent sexual encounters. Young people preferred (but they are also left with no other option than) to seek information from discreet sources, including friends and partners, leaflets and the mass media. In addition, service providers misunderstood young people's purchasing behaviour, characterized by buying ECs quickly and feeling too embarrassed to ask questions, as a rejection of counselling. The resultant lack of information about ECs sometimes led to confusion about how to take the pills. CONCLUSIONS: The attitudes and beliefs of key stakeholders and service providers result in a lack of clear information on ECs available to young people. This could be addressed by improving the information leaflet, providing clear instructions of use on blister packages, strategically distributing posters, and service providers adopting a more proactive attitude.
Assuntos
Anticoncepção Pós-Coito/estatística & dados numéricos , Conhecimentos, Atitudes e Prática em Saúde , Comportamento de Busca de Informação , População Urbana , Adolescente , Adulto , Atitude do Pessoal de Saúde , Anticoncepção Pós-Coito/tendências , Aconselhamento Diretivo , Etiópia , Feminino , Humanos , Entrevistas como Assunto , Masculino , Educação de Pacientes como Assunto , Farmacêuticos , Pesquisa Qualitativa , Comportamento Sexual , Inquéritos e Questionários , Adulto JovemRESUMO
OBJECTIVE: To determine long-term trends in emergency contraception (EC) management by general practitioners in Australia. DESIGN, SETTING AND PARTICIPANTS: Data from April 2000 to March 2012 were drawn from the BEACH (Bettering the Evaluation and Care of Health) program, a continuous cross-sectional survey of GP activity. We analysed consultations involving EC management, unwanted pregnancy management and emergency contraceptive pill (ECP) prescribing per 1000 GP encounters with women aged 14-54 years. Summary statistics were calculated with 95% confidence intervals. RESULTS: In 2000-2001, GPs managed EC problems at a rate of 5.50 per 1000 encounters (95% CI, 4.37-6.63). From 2004, after the ECP became available over the counter (OTC) in pharmacies, EC management, which includes ECP prescription, progressively declined. By 2011-2012, only 1.43 EC problems were managed per 1000 encounters (95% CI, 0.84-2.02) and only 0.48 ECP prescriptions were provided per 1000 encounters (95% CI, 0.14-0.82). Yet the management rate of unwanted pregnancy problems stayed relatively constant (rate in 2000-2001, 0.95 per 1000 encounters; 95% CI, 0.40-1.50; rate in 2011-2012, 0.88 per 1000 encounters; 95% CI, 0.41-1.36). CONCLUSION: Low rates of EC management by GPs since ECP became available OTC suggest that women may be obtaining information on EC elsewhere. Further investigation is needed to uncover the sources of this information and its acceptability and application by Australian women.
Assuntos
Anticoncepção Pós-Coito/estatística & dados numéricos , Anticoncepcionais Pós-Coito/administração & dosagem , Conhecimentos, Atitudes e Prática em Saúde , Encaminhamento e Consulta/estatística & dados numéricos , Adolescente , Adulto , Austrália/epidemiologia , Anticoncepção Pós-Coito/métodos , Anticoncepção Pós-Coito/tendências , Estudos Transversais , Feminino , Clínicos Gerais , Humanos , Pessoa de Meia-Idade , Encaminhamento e Consulta/tendênciasRESUMO
Emergency contraception (EC) is a safe and effective method which is used to prevent unwanted pregnancy after unprotected sexual intercourse. Many of the unwanted pregnancies end in unsafe abortions. The search for an ideal contraceptive, which does not interfere with spontaneity or pleasure of the sexual act, yet effectively controls the fertility, is still continuing. Numerous contraceptive techniques are available, yet contraceptive coverage continues to be poor in India. Thus, even when not planning for a pregnancy, exposure to unprotected sex takes place often, necessitating the use of emergency contraception. This need may also arise due to failure of contraceptive method being used (condom rupture, diaphragm slippage, forgotten oral pills) or following sexual assault. Emergency contraception is an intervention that can prevent a large number of unwanted pregnancies resulting from failure of regular contraception or unplanned sexual activity, which in turn helps in reducing the maternal mortality and morbidity due to unsafe abortions. However, a concern has been expressed regarding repeated and indiscriminate usage of e-pill, currently the rational use of emergency contraception is being promoted as it is expected to make a significant dent in reducing the number of unwanted pregnancies and unsafe abortions. In fact, since the introduction of emergency contraception, the contribution of unsafe abortion towards maternal mortality has declined from 13 to 8 per cent.
Assuntos
Anticoncepção Pós-Coito/métodos , Anticoncepção Pós-Coito/tendências , Saúde da Mulher/tendências , Aborto Induzido/estatística & dados numéricos , Anticoncepção Pós-Coito/efeitos adversos , Anticoncepção Pós-Coito/economia , Contraindicações , Feminino , Humanos , GravidezRESUMO
Emergency contraception can be used by women after sexual intercourse in an effort to prevent an unintended pregnancy. Roughly one-half of all pregnancies in the United States are unintended (1,2). The FDA first approved emergency contraceptive pills in 1998, but there is evidence of limited use of hormonal contraceptives for emergency contraception since the 1960s (3,4). Now, there are at least four brands of emergency contraceptive pills; most are available over the counter for women aged 17 and over (5). Although insertion of a copper intrauterine device can be used for emergency contraception (1,4), this report focuses only on emergency contraceptive pills. This report describes trends and variation in the use of emergency contraception and reasons for use among sexually experienced women aged 15-44 using the 2006-2010 National Survey of Family Growth.
Assuntos
Anticoncepção Pós-Coito/estatística & dados numéricos , Gravidez não Desejada , Adolescente , Adulto , Anticoncepção Pós-Coito/psicologia , Anticoncepção Pós-Coito/tendências , Feminino , Acessibilidade aos Serviços de Saúde , Inquéritos Epidemiológicos , Humanos , Estado Civil , Gravidez , Estados Unidos , Adulto JovemRESUMO
OBJECTIVES: The UK Faculty of Sexual & Reproductive Healthcare (FSRH) has recommended that for emergency contraception (EC) the health professional should discuss individual needs and inform women of the different methods, efficacy, adverse effects, interactions, eligibility and additional contraception. In our sexual and reproductive health care service (Liverpool and Knowsley, UK), revised guidance was issued in early 2012, reflecting Faculty advice. We studied (1) how our use of EC changed, (2) which methods were offered and how this changed, (3) which method was chosen by women who were offered all three UK licensed methods of EC and (4) the appropriateness of the offer of only levonorgestrel (LNG). METHODS: We studied a total of 2989 case records in the 3 months before and 3 months following the adoption by our service of the 2011 FSRH guidance. This was a retrospective review of charts undertaken by interrogating our computerised Excelicare(®) system of clinical records. All EC episodes in the two 3-month periods were analysed, covering October-December 2011 and March-May 2012. Additionally, three non-probabilistic, purposeful samples of representative practitioners' charts were examined in groups of women offered all methods [and choosing either ulipristal acetate (UPA) or LNG] or who were offered LNG only. RESULTS: The use of LNG fell from 93.0% of EC issued to 76.0%; UPA use rose from 3.0% to 18.7%. In the second 3-month period, of the women offered all three methods, 54.9% chose LNG and 39.8% UPA. LNG-only offers in our judgement were clinically appropriate in 62.5% cases of such offers. CONCLUSIONS: Comparing the second period with the first, more women were offered all three methods, the use of LNG fell (93.0% to 76.0%) and that of UPA increased (3.0% to 18.7%). Women were encouraged to exercise choice. However, increasing choice in our service did not lead to a wholesale change from LNG to UPA.
Assuntos
Anticoncepção Pós-Coito/estatística & dados numéricos , Guias de Prática Clínica como Assunto , Padrões de Prática Médica/estatística & dados numéricos , Anticoncepção Pós-Coito/tendências , Anticoncepcionais/uso terapêutico , Uso de Medicamentos/estatística & dados numéricos , Uso de Medicamentos/tendências , Feminino , Humanos , Dispositivos Intrauterinos de Cobre/estatística & dados numéricos , Levanogestrel/uso terapêutico , Norpregnadienos/uso terapêutico , Padrões de Prática Médica/tendências , Estudos Retrospectivos , Reino UnidoRESUMO
Despite many highly effective methods of contraception are available nowadays, many pregnancies are unintended. Emergency contraception (EC) is the use of drug or device after unprotected intercourse to prevent an unwanted pregnancy. It is a woman's last chance to prevent unintended pregnancy. Nevertheless the confusion about mechanisms of action, side effects, clinical efficacy and controindications makes the intervention underused in every setting investigated. So far levonorgestrel (LNG) has been considered the gold standard for oral EC. Today, a new type of second generation progesterone receptor modulator, ulipristal acetate (UPA) has been proposed as a more effective drug than LNG in prevention of unwanted pregnancies by delaying or inhibiting ovulation; even if many other devices are disposable in commerce. We revised the literature to concern most of the data available on the role of EC and moreover clarifying the available methods, the action windows of the accessible devices, the adverse events and the controindications.
Assuntos
Comportamento Contraceptivo , Anticoncepção Pós-Coito , Comportamento Contraceptivo/tendências , Anticoncepção Pós-Coito/efeitos adversos , Anticoncepção Pós-Coito/tendências , Anticoncepcionais Pós-Coito/administração & dosagem , Anticoncepcionais Pós-Coito/efeitos adversos , Contraindicações , Serviços de Planejamento Familiar/tendências , Feminino , Humanos , Masculino , Aceitação pelo Paciente de Cuidados de SaúdeAssuntos
Anticoncepção Pós-Coito , Saúde Global , Política de Saúde , Saúde da Mulher , Atitude Frente a Saúde , Anticoncepção Pós-Coito/métodos , Anticoncepção Pós-Coito/psicologia , Anticoncepção Pós-Coito/tendências , Anticoncepcionais Pós-Coito/administração & dosagem , Feminino , Política de Saúde/tendências , Acessibilidade aos Serviços de Saúde , Humanos , Medicamentos sem Prescrição/administração & dosagemRESUMO
Although contraception is widely available in France, contraceptive failure remains high. However a number of modifications in contraceptive methods have been developed and should help reduce contraceptive failure. Among those, information and improvement of access to contraception are very important. Recent advances in contraceptive practice have also contributed to improve clinical tolerance and subsequently compliance. Finally, emergency contraception has evolved as well.
Assuntos
Anticoncepção/tendências , Adolescente , Adulto , Anticoncepção/economia , Anticoncepção/métodos , Comportamento Contraceptivo , Anticoncepção Pós-Coito/tendências , Anticoncepcionais/administração & dosagem , Anticoncepcionais/efeitos adversos , Custos e Análise de Custo , Feminino , França , Humanos , Pessoa de Meia-Idade , GravidezRESUMO
Women have been using emergency contraception (EC) for decades. Population studies have not shown that increased access to EC decreases abortion rates this is likely because of inconsistent and infrequent use even when it is available. Special populations, such as adolescents, have been shown to be just as good as their adult counterparts in comprehending EC instructions, and its use does not lead to more risky sexual practices or behaviors. There is little evidence on the administration of EC to victims of sexual assault, but what is available reveals more women who are victims of sexual assault should be offered EC as an option. Methods of EC include high doses of ethinyl estradiol; DES; Danzaol; combination ethinyl estradiol with a progestin; progestin alone and copper IUDs. This review describes the history of EC as well as newer medications such as the antiprogestins (gestrinone and uliprisatal acetate) and cyclooxygenase inhibitors(meloxifam). These methods have been added to the armamentarium and may prove to be more effective than current regimens. Finding a product that is highly effective with minimal side effects is a worthy goal, for it presents a woman with her last chance to prevent an unwanted pregnancy.
Assuntos
Anticoncepção Pós-Coito/tendências , Anticoncepcionais Hormonais Pós-Coito/uso terapêutico , Anticoncepcionais Sintéticos Pós-Coito/uso terapêutico , Adolescente , Comportamento do Adolescente , Adulto , Anticoncepção Pós-Coito/métodos , Aconselhamento , Feminino , Fidelidade a Diretrizes , Conhecimentos, Atitudes e Prática em Saúde , Acessibilidade aos Serviços de Saúde/tendências , Humanos , Dispositivos Intrauterinos/tendências , Educação de Pacientes como Assunto , Gravidez , Gravidez não Desejada , Estupro , Medição de RiscoRESUMO
Emergency contraception (EC) is the postcoital method of pregnancy prevention. Three methods of EC are used in the United States: (1) levonorgestrel-only pills, Plan B (Barr Pharmaceuticals, LLC, New Jersey) (2) combined estrogen and progestin pills, and (3) the copper intrauterine device. Used within 120 hours after unprotected sexual intercourse, EC reduces the risk of pregnancy by 60 to 94%. EC is a critical component of medical care for sexual assault survivors, and several states have laws mandating this standard of care. Levonorgestrel-only EC is available to women >or=17 years of age without a prescription. Women who were counseled by their clinician about EC were 11 times more likely to use EC in the following 12 months. Advance provision of EC to women has not been found to decrease rates of unintended pregnancy compared with routine pharmacy access; however, women routinely prefer advance provision. The newly approved by the Food and Drug Administration single-dose EC, Plan B One-Step (Barr Pharmaceuticals, LLC), may affect unintended pregnancy rates among EC users by simplifying use.